5th Zurich Brain Metastasis Symposium
Advances in systemic targeted therapy and immunotherapy have dramatically improved outcome at least in some types of solid cancer. However, metastasis to the central nervous system remains a major diagnostic and therapeutic challenge, notably in long-term survivors with cancers.
Standort
Grosser Hörsaal Ost USZ & hybrid
Datum
25.01.2024
Zeit
9.00 a.m. - 5.00 p.m.
Credits
SGMO 6, SSRO 7
Here we invite you to our 5th Zurich Brain Metastasis Symposium that will provide state-of-the-art presentations on current and future diagnostic and therapeutic approaches for patients with brain and leptomeningeal metastasis.
Program
| 9.00 a.m. | Welcome Matthias Guckenberger, University Hospital Zurich Michael Weller, University Hospital Zurich |
|---|---|
| Session 1: Isabell Witzel | |
| 9.10 a.m. | Novel diagnostic approaches for CNS metastasis Pieter Wesseling, Amsterdam University Medical Centers, Amsterdam and Princess Máxima Center for Pediatric Oncology, Utecht, The Netherlands |
| 9.40 a.m. | Where do we stand with liquid biopsy in CNS metastases? Anna Bettina Sobottka-Brillout, University Hospital Zurich |
| 10.10 a.m. | Coffee Break |
| 10.30 a.m. | Insights into the proteomic landscape of brain metastases Tobias Weiss, University Hospital Zurich |
| 11.00 a.m. | Markers of response or hyperprogression to immune checkpoint inhibition Mitchell Levesque, University Hospital Zurich |
| Session 2: Nicolaus Andratschke | |
| 11.30 a.m. | New Challenges and opportunities for neurosurgeons in the management of brain metastasis Marian Neidert, Cantonal Hospital St. Gallen |
| 12.00 p.m. | New challenges and opportunities for Radiation Oncology in the management of brain metastasis Giuseppe Minniti, University La Sapienza, Rome |
| 12.30 p.m. | Lunch Break |
| 1.30 p.m. | Controversies from the CNS Metastasis Guideline process: screening, timing of radiotherapy, intrathecal pharmacotherapy Matthias Preusser, University Hospital Vienna |
| 2.00 p.m. | CNS trials at the Comprehensive Cancer Center Zurich Emilie Le Rhun, University Hospital Zurich |
| 2.15 p.m. | Pharmacoscopy for CNS metastasis Berend Snijder, ETH Zurich |
| Session 3: Andreas Wicki | |
| 2.30 p.m. | Blood brain barrier and phrmacokinetic and phase 0 studies Dieta Brandsma, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam |
| 3.00 p.m. | Assessing response in CNS metastases trials: the RANO perspective Lakshmi Nayak, Harvard University, Boston |
| 3.30 p.m. | Coffee Break |
| 3.50 p.m. | How to integrate brain metastasis into clinical trials: lessons from melanoma Reinhard Dummer, University Hospital Zurich |
| Keynote Lecture: Michael Weller | |
| 4.20 p.m. | Neoadjuvant immunotherapy: a perspective and a vision Alexander Eggermont, Prinses Máxima Centrum voor Kinderoncologie, Utrecht |
| 4.50 p.m. | Wrap-up |
